Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azvudine dose-exploration study in treatment-naive HIV patients
ChiCTR2000031964Phase 2Completed
- Sponsor
- Beijing YouAn Hospital
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of azvudine in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (4 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Number of subjects with HIV viral load below 50 copies/mL after treatment. Started Oct 2017; status: completed.
02
Drugs
azvudine
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on ChiCTR2000031964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031964.